04.07.2021 - By Core IM Team
How does cost, potency, and bleeding risk affect which antiplatelet you choose P2Y12 inhibitors? How long after starting, do you feel comfortable stopping DAPT on a patient? How do you manage DAPT in patients who need anticoagulation?
Show notes, Transcript and References: https://www.coreimpodcast.com/2021/04/07/5-pearls-on-dual…platelet-therapy/ (https://www.coreimpodcast.com/2021/04/07/5-pearls-on-dual-antiplatelet-therapy/)
Join Our Team (https://www.coreimpodcast.com/join-us/)
(https://www.coreimpodcast.com/2021/04/07/5-pearls-on-dual-antiplatelet-therapy/)Time stamps
* 02:35 Indications
* 08:52 Medications
* 17:37 Duration
* 28:23 De-escalation
* 30:55 Anticoagulation
Tags: IM Core, CoreIM, anticoagulation, DAPT, acute coronary syndrome, stents, thrombosis, bleeding risk, cardiology, hospitalist, primary care
Find the best disability insurance for you: https://www.patternlife.com/disability-insurance?campid=497840
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy